Neuroimmune dysregulation and comorbidity mechanisms of major depressive disorder and migraine - Takeaways - MDSpire

Neuroimmune dysregulation and comorbidity mechanisms of major depressive disorder and migraine

  • By

  • Guining Liang

  • Qi Huang

  • Wenyi Song

  • Mika Pan

  • Qingyan Wei

  • Jingyi Zeng

  • Youfeng Xie

  • Yating Lan

  • Chun Zou

  • Xiuying Liu

  • Xiaohua Huang

  • Donghua Zou

  • January 14, 2026

  • 0 min

Share

  • 1

    Major depressive disorder (MDD) is highly prevalent, particularly among women, and significantly impacts mental health and quality of life.

  • 2

    MDD frequently coexists with migraine, with patients exhibiting a 2- to 3-fold increased risk of migraine compared to the general population.

  • 3

    Astrocyte and oligodendroglial gene networks show specific dysregulation patterns in MDD and migraine, indicating shared pathophysiological mechanisms.

  • 4

    Single-nucleus RNA sequencing (snRNA-seq) is utilized to identify common gene expression signatures in MDD and migraine, focusing on glial and immune cell lineages.

  • 5

    Understanding the molecular interactions between MDD and migraine is crucial for developing targeted therapeutic strategies for their comorbidity.

Original Source(s)

Neuroimmune dysregulation and comorbidity mechanisms of major depressive disorder and migraine

  • by Guining Liang, Qi Huang, Wenyi Song, Mika Pan, Qingyan Wei, Jingyi Zeng, Youfeng Xie, Yating Lan, Chun Zou, Xiuying Liu, Xiaohua Huang, Donghua Zou

  • January 14, 2026

Related Content

Premenstrual syndrome, premenstrual dysphoric disorder, and coping strategies in women with menstrual migraine

Spreading depolarization triggers pro- and anti-inflammatory signalling: a potential link to headache

IHS, ACP Differ on Migraine Tx

Experts highlight differences between IHS and ACP recommendations as newer therapies reshape acute and preventive migraine care